Literature DB >> 10781008

Cisplatin-induced early and delayed emesis in the pigeon.

S Tanihata1, H Igarashi, M Suzuki, T Uchiyama.   

Abstract

1. Intravenously injected cisplatin at a dose of 4 mg kg(-1) induced early and delayed emesis in all pigeons without occurrence of lethality during a 72 h observation period. The early emetic response occurred with a latency of 81.3+/-8.0 min (n=15) and reached a peak at 2 - 3 h, and decreased gradually within 8 h after injection. Then the delayed emetic response, whose peak was found between 10 to 23 h, lasted up to 48 h. The emetic response markedly declined after 48 h. 2. Reserpine markedly reduced monoamine levels in both brain and intestine and completely abolished the early and delayed emesis. Dexamethasone markedly reduced not only the early but also the delayed emetic responses. p-Chlorophenylalanine decreased the level of serotonin in brain and intestine without affecting noradrenaline and dopamine and partly reduced the early emetic response, but did not affect delayed emesis. 3. Bilateral vagotomy prolonged the latency time to the onset of early emesis, and reduced the emetic responses in both the early and delayed phases. 4. The above results suggest that the cisplatin-induced early emesis in the pigeon is partially mediated via the vagal nerve and reserpine-sensitive monoaminergic systems including the serotonergic system; the delayed emesis is associated with monoaminergic but not the serotonergic systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781008      PMCID: PMC1572039          DOI: 10.1038/sj.bjp.0703283

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis.

Authors:  B Costall; A M Domeney; R J Naylor; F D Tattersall
Journal:  Neuropharmacology       Date:  1986-08       Impact factor: 5.250

2.  Antiemetic properties of the 5HT3-receptor antagonist, GR38032F.

Authors:  R Stables; P L Andrews; H E Bailey; B Costall; S J Gunning; J Hawthorn; R J Naylor; M B Tyers
Journal:  Cancer Treat Rev       Date:  1987-12       Impact factor: 12.111

3.  The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.

Authors:  J Hawthorn; K J Ostler; P L Andrews
Journal:  Q J Exp Physiol       Date:  1988-01

4.  Preclinical toxicology of platinum analogues in dogs.

Authors:  P Lelieveld; W J van der Vijgh; D van Velzen
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

5.  Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats.

Authors:  L E McCarthy; H L Borison
Journal:  Cancer Treat Rep       Date:  1984-02

6.  The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon.

Authors:  P Preziosi; M D'Amato; R Del Carmine; M Martire; G Pozzoli; P Navarra
Journal:  Eur J Pharmacol       Date:  1992-10-20       Impact factor: 4.432

7.  Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: a new experimental model.

Authors:  N Matsuki; S Ueno; T Kaji; A Ishihara; C H Wang; H Saito
Journal:  Jpn J Pharmacol       Date:  1988-10

8.  [Experimental study on the control of cisplatin-induced emesis in dogs].

Authors:  J Ito; M Okada; T Abo; Y Okamoto; T Yamashita; K Takahashi
Journal:  Gan To Kagaku Ryoho       Date:  1987-03

9.  Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.

Authors:  B Costall; A M Domeney; R J Naylor; F D Tattersall
Journal:  Neuropharmacology       Date:  1987-09       Impact factor: 5.250

10.  The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.

Authors:  W L Smith; E M Callaham; R S Alphin
Journal:  J Pharm Pharmacol       Date:  1988-02       Impact factor: 3.765

View more
  8 in total

1.  Nausea and emesis: still an unsolved problem in cancer patients?

Authors:  Jørn Herrstedt
Journal:  Support Care Cancer       Date:  2002-01-31       Impact factor: 3.603

Review 2.  Opportunities for the replacement of animals in the study of nausea and vomiting.

Authors:  A M Holmes; J A Rudd; F D Tattersall; Q Aziz; P L R Andrews
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

3.  Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates.

Authors:  Ihsan Ullah; Fazal Subhan; Muhammad Ayaz; Rehmat Shah; Gowhar Ali; Ikram Ul Haq; Sami Ullah
Journal:  BMC Complement Altern Med       Date:  2015-02-26       Impact factor: 3.659

4.  Synthetic and natural antioxidants attenuate cisplatin-induced vomiting.

Authors:  Javaid Alam; Fazal Subhan; Ihsan Ullah; Muhammad Shahid; Gowhar Ali; Robert D E Sewell
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-13       Impact factor: 2.483

Review 5.  Mechanisms of Chemotherapy-Induced Neurotoxicity.

Authors:  Halina Was; Agata Borkowska; Ana Bagues; Longlong Tu; Julia Y H Liu; Zengbing Lu; John A Rudd; Kulmira Nurgali; Raquel Abalo
Journal:  Front Pharmacol       Date:  2022-03-28       Impact factor: 5.810

6.  Prokinetic and Laxative Effects of Chrozophora tinctoria Whole Plant Extract.

Authors:  Ayaz Ali Sher; Arshad Iqbal; Naveed Muhammad; Syed Lal Badshah; Abdul-Hamid Emwas; Mariusz Jaremko
Journal:  Molecules       Date:  2022-03-26       Impact factor: 4.411

7.  Phytotherapeutic Approach in the Management of Cisplatin Induced Vomiting; Neurochemical Considerations in Pigeon Vomit Model.

Authors:  Ihsan Ullah; Fazal Subhan; Muhammad Shahid; Nisar Ahmad; Rehmat Shah; Javaid Alam; Ikram Ul Haq; Rahim Ullah; Muhammad Ayaz; H C Ananda Murthy
Journal:  Oxid Med Cell Longev       Date:  2022-09-13       Impact factor: 7.310

8.  Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences.

Authors:  Ihsan Ullah; Fazal Subhan; Javaid Alam; Muhammad Shahid; Muhammad Ayaz
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.